Antisense oligo-mediated multiple exon skipping in a dog model of duchenne muscular dystrophy.
about
Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndromeDystrophin-deficient large animal models: translational research and exon skippingAntisense therapy in neurologyLong-term efficacy of systemic multiexon skipping targeting dystrophin exons 45-55 with a cocktail of vivo-morpholinos in mdx52 miceDigital Droplet PCR for the Absolute Quantification of Exon Skipping Induced by Antisense Oligonucleotides in (Pre-)Clinical Development for Duchenne Muscular Dystrophy.Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs.Multiple exon skipping strategies to by-pass dystrophin mutations.Targeting RNA splicing for disease therapy.Mutation types and aging differently affect revertant fiber expansion in dystrophic mdx and mdx52 mice.Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy.Development of multiexon skipping antisense oligonucleotide therapy for Duchenne muscular dystrophyImpaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?New developments in the use of gene therapy to treat Duchenne muscular dystrophy.New developments in exon skipping and splice modulation therapies for neuromuscular diseases.Antisense oligonucleotides: the next frontier for treatment of neurological disorders.Making sense of antisense oligonucleotides: A narrative review.Designing Effective Antisense Oligonucleotides for Exon Skipping.Skipping Multiple Exons to Treat DMD-Promises and Challenges.
P2860
Q21284684-08AB6D81-BE86-4E05-B60A-AACEEA107F33Q26781901-08E374A9-A551-46F5-B385-0DCDD0D9B0A3Q34608717-6BE32CE2-23CA-4705-95CA-F1ED2501089EQ35133936-3BB62F52-B005-4A7C-829E-3C40BE0C0DC3Q36128670-CFFC357A-E863-486F-A32E-C596788E26B3Q36297940-CF3E829B-8E99-453D-8CBA-AFD4A79177B7Q36369845-2D6C1CC5-50B9-4DED-8FE8-48C133F2F28BQ36780738-17A66EF3-5482-4D0B-A19E-52E05A132BFAQ37042659-1C370AF5-CEE1-4A5E-9B03-4CAD974CE9F3Q37053612-B3093F48-73E2-42A4-A522-1C8992F0A011Q37105210-56298B8D-E281-452A-BC20-0A1C6AF08115Q37479592-5584C92F-1E77-48AD-90F7-21DC22BE746FQ38014906-57047B94-AD4D-4544-AB0A-973AB96F092BQ38168863-C4E3850A-182B-4858-9DC4-984C8B626313Q38195295-F9FCFCF3-4775-4803-BBB7-377D13402628Q47344432-F3079D8E-0DAA-4243-BD5B-7010B5772172Q47438944-F131A8DD-8784-496B-9F5D-854A6242D0E5Q47606988-AD509104-F898-48A0-A97E-E7B3D0AD8AB1Q52429827-BB71B0FB-DFC0-465C-AC88-A56F3397548E
P2860
Antisense oligo-mediated multiple exon skipping in a dog model of duchenne muscular dystrophy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Antisense oligo-mediated multi ...... f duchenne muscular dystrophy.
@ast
Antisense oligo-mediated multi ...... f duchenne muscular dystrophy.
@en
type
label
Antisense oligo-mediated multi ...... f duchenne muscular dystrophy.
@ast
Antisense oligo-mediated multi ...... f duchenne muscular dystrophy.
@en
prefLabel
Antisense oligo-mediated multi ...... f duchenne muscular dystrophy.
@ast
Antisense oligo-mediated multi ...... f duchenne muscular dystrophy.
@en
P2093
P2860
P1476
Antisense oligo-mediated multi ...... f duchenne muscular dystrophy.
@en
P2093
Eric Hoffman
Shin'ichi Takeda
Toshifumi Yokota
P2860
P304
P356
10.1007/978-1-61737-982-6_20
P407
P577
2011-01-01T00:00:00Z